Search For "lancet study"
"Reduction in foreign funds requires restructuring, but won't impact healt
Updated : 1 month, 2 weeks ago IST
A recent Lancet Global Health study warning that sharp reductions in global development assistance could reverse health gains and lead to millions of additional deaths worldwide has triggered discussion among Indian health experts, who maintain that while India may need to restructure som
Read More
As world approaches "irreversible harm," deaths due to heat may rise fivef
Updated : 2 years, 4 months ago IST
The latest edition of the Lancet Countdown on Health and Climate Change has revealed the grave and mounting threat to health of further delayed action on climate change, with the world likely to experience a "4.7-fold increase in heat-related deaths by mid-century."
Read More
Over 42 lakh deaths prevented in India due to COVID vaccination in 2021: L
Updated : 3 years, 9 months ago IST
New Delhi [India], June 24 (ANI): COVID-19 vaccination drive in India prevented over 42 lakh deaths in 2021, according to the Lancet Infectious Diseases journal, which is based on findings on estimates of "excess" mortalities in the country during the pandemic.
Read More
Half of Covid survivors show one symptom even after 2 years: Lancet Journa
Updated : 3 years, 10 months ago IST
New Delhi [India], May 12 (ANI): Two years after getting infected with COVID-19, health outcomes of people who have suffered hospitalisation, reported at least one symptom, said a follow-up study by The Lancet medical journal on Thursday.
Read More
Lancet study stating that protection offered by Covishield declines after
Updated : 4 years, 3 months ago IST
New Delhi [India], December 23 (ANI): The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months, has been misquoted, said experts.
Read More
Covaxin 50 pc effective against symptomatic COVID: Lancet study
Updated : 4 years, 4 months ago IST
New Delhi [India], November 24 (ANI): Two doses of COVID-19 vaccine Covaxin (BBV152) are 50 per cent effective against symptomatic COVID-19 disease, according to the first real-world assessment of the COVID-19 vaccine published in the Lancet Infectious Diseases journal.
Read More
UK's Oxford vaccine phase-2 trial indicates strong results in older adults
Updated : 5 years, 4 months ago IST
New Delhi [India], November 19 (ANI): In a major development, UK's Covid-19 vaccine has shown similar strong immune response in healthy older adults -aged 56 years and above- to those seen in people between 18 to 55 years, according to findings from a phase-2 trial.
Read More
Authors retract Lancet study on HCQ drug over unavailability of full data
Updated : 5 years, 9 months ago IST
Washington D.C. [USA], June 5 (ANI): Three authors involved in a Lancet article that drew scrutiny over the trial of the antimalarial drug-- hydroxychloroquine-- for curing patients infected with COVID-19 said they retracted items related to it over unavailability of full data set behind the
Read More
Halting hydroxychloroquine trials based on faulty Lancet study is 'knee je
Updated : 5 years, 10 months ago IST
New Delhi [India], May 30 (ANI): Council of Scientific and Industrial Research (CSIR) Director-General Shekhar Mande, Institute of Genomics and Integrative Biology (IGIB) Delhi Director Anurag Agarwal and Chennai Mathematical Institute (CMI) Chennai Director Rajeev Karandikar have written to
Read More
Lancet study is not randomised clinical trial, only analysis of hospital r
Updated : 5 years, 10 months ago IST
New Delhi [India], May 27 (ANI): Dismissing the reports of health risks from Hydroxychloroquine (HCQ) as per simmering reports cited by the World Health Organisation (WHO), Shekher Mande, Director General of the Council of Scientific and Industrial Research (CSIR), India, said on Wednesday t
Read More